Stifel Nicolaus Keeps Their Buy Rating on Neurogene (NGNE)
Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Neurogene (NGNE – Research Report) today and set a price target of $46.00. The ...
Spyre Therapeutics (SYRE) Gets a Buy from Stifel Nicolaus
Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report) today and set a price target ...
Stifel raises SiteOne stock rating, trims price target to $140
Stifel analysts adjusted their stance on SiteOne Landscape Supply (NYSE: NYSE:SITE), upgrading the stock from 'Hold' to 'Buy' while slightly reducing the price target to $140 from $145. The upgrade ...
Hosted on MSN2m
Stifel maintains hold on Restaurant Brands with $68 target
On Monday, Stifel analysts maintained their "Hold" rating on Restaurant ... including 10 additional ProTips and comprehensive financial metrics, investors can access the full Pro Research Report, ...